Cymabay Therapeutics Inc. (CBAY)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
StemPoint Capital

Michelle Ross

0 $0 0%
2.
Perceptive Advisors

Joseph Edelman

0 $0 0%
3.
RA Capital Management

Peter Kolchinsky

0 $0 0%
4. 0 $0 0%
5. 0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.95 51,301 Officer, Director 171,301 2022-06-06 Filing
$3.04 20,000 Officer 20,000 2022-01-19 Filing
$4.30 5,000 Officer, Director 120,000 2019-10-10 Filing
$5.55 3,100 Officer, Director 115,000 2019-09-23 Filing
$5.50 1,900 Officer, Director 111,900 2019-09-20 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$31.97 6,000 Director 0 2024-02-12 Filing
$23.68 3,125 Officer 15,000 2024-01-19 Filing
$23.68 8,334 Officer 15,000 2024-01-19 Filing
$23.66 1,916 Officer 15,000 2024-01-19 Filing
$23.66 2,778 Officer 15,000 2024-01-19 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 9,610,239 $226,993,846 0%
2. 6,306,149 $148,951,239 0%
3. 6,103,797 $144,178,716 0.08%
4. 3,992,711 $94,307,835 0.07%
5. 3,267,927 $77,188,437 0.03%
News See All